Fully integrated end-to-end solutions

Solutions designed for the future.

BD offers a full suite of advanced cervical cancer screening products and services that empower clinicians and laboratories to meet the needs of the rapidly changing cervical cancer screening landscape and adapt to evolving guidelines.

A complete portfolio of collection devices, assays and instruments to keep you ahead of the curve.

Acting as a single source provider for both HPV and cytology testing, BD’s cervical cancer screening portfolio offers integrated solutions from sample to result, for every laboratory setting and any cervical cancer screening paradigm, giving you the flexibility that you need to transform your lab and stay ahead of the curve.

Using BD SurePath™ offers full traceability for cytology and HPV testing from a single specimen.

Flexible solutions so you can adapt to all screening paradigms.

The BD SurePath™ Liquid-based Pap Test and the BD Onclarity™ HPV Assay provide HPV primary screening, co-testing and cytology primary with ASC-US reflex.

HPV Primary Screening

The BD Onclarity™ HPV Assay is a DNA-based PCR assay with validated performance approved for HPV primary cervical cancer screening, extended genotyping and self-collected vaginal specimens.¹

The BD SurePath™ Collection Vial provides an FDA and CE-marked collection vial for HPV primary screening and additional cytology testing of HPV positive cases.²

Co-testing

The BD SurePath™ Collection Vial provides an FDA and CE-marked single source vial for cytology and HPV co-testing with the BD SurePath™ Liquid-based Pap Test and the BD Onclarity™ HPV Assay.^1,2

Cytology Primary Screening

The BD SurePath™ Liquid-based Pap Test is an FDA and CE-marked solution for cytology primary screening,2 with higher cervical disease detection and lower unsatisfactory rate compared to conventional cytology and other liquid-based cytology (LBC) devices.³

The BD Onclarity™ HPV Assay provides an HPV testing solution for triage of ASC-US cytology.¹

BD SurePath™ Collection Vial

The BD SurePath™ Collection Vial is FDA and CE-marked for use with the BD SurePath™ Liquid-based Pap Test and the BD Onclarity™ HPV Assay.^1,2

The BD SurePath™ Collection Vial provides a single FDA and CE-marked collection device approved for all 3 screening paradigms, offering the flexibility you need to adapt to changing screening guidelines.^1,2

Versatile, integrated and scalable instrumentation that fits your laboratory’s size.

Choose the most appropriate solutions according to your laboratory's volume and the level of automation you require.

HPV TESTING	BD Viper™ LT System	BD Viper™ LT System or BD COR™ System	BD COR™ System
CYTOLOGY TESTING	BD PrepMate™ Automated Accessory Manual slide preparation	BD PrepMate™ Automated Accessory or BD Totalys™ MultiProcessor BD Totalys™ SlidePrep	BD Totalys™ MultiProcessor BD Totalys™ SlidePrep BD FocalPoint™ GS Imaging System

What are your HPV testing needs? What are your cytology testing needs?

Fully integrated end-to-end solutions.

BD cervical cancer screening instruments offer a simple workflow, enable minimal hands-on time and provide actionable results, bringing your lab to a new level of performance and confidence through integrated automation.

Fully integrated end-to-end solutions

HPV testing LEARN MORE	Cytology testing LEARN MORE

ASC-US, atypical squamous cells of undetermined significance; DNA, deoxyribonucleic acid; FDA, Food and Drug Administration; HPV, human papillomavirus; LBC, liquid-based cytology; Pap, Papanicolaou; PCR, polymerase chain reaction.

1. BD Onclarity™ HPV Assay Package Insert (8089899).
2. BD SurePath™ Collection Vial Package Insert (500017013).
3. Nance KV. Diagn Cytopathol. 2007;35(3):148–53.